Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
公司代碼ALUR
公司名稱Allurion Technologies Inc
上市日期Mar 29, 2021
CEOGaur (Shantanu)
員工數量134
證券類型Ordinary Share
年結日Mar 29
公司地址11 Huron Dr Ste 200
城市NATICK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編01760
電話15086474000
網址https://www.allurion.com/en
公司代碼ALUR
上市日期Mar 29, 2021
CEOGaur (Shantanu)